Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108208 | 0.85 | HRH4 (0.35) | CYP19A1MAOA | |
| Hydrochloric Acid SCHEMBL17048491 | 0.84 | HRH4 (0.34) | CYP19A1MAOA | |
| SCHEMBL9965874 | 0.81 | CYP19A1 (0.34) | CYP19A1 | |
| SCHEMBL9965871 | 0.81 | CYP19A1 (0.34) | CYP19A1 | |
| SCHEMBL4309077 | 0.81 | MAOA (0.36) | CYP19A1MAOA | |
| SCHEMBL27989235 | 0.78 | CYP2B6 (0.40) | CYP19A1 | |
| SCHEMBL2877085 | 0.78 | CYP2B6 (0.44) | CYP19A1 | |
| SCHEMBL18325457 | 0.76 | CYP2B6 (0.47) | CYP19A1 | |
| SCHEMBL18325220 | 0.76 | CYP2B6 (0.47) | CYP19A1 | |
| SCHEMBL2573428 | 0.72 | FDPS (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858872-A | Heterocyclic EGFR inhibitors for the treatment of cancer | 缆图药品公司 | 2024-04-09 | — | — | CN | disclosed |
| WO-2022271612-A1 | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER | BLUEPRINT MEDICINES CORPORATION (US) | 2022-12-29 | — | — | WO | disclosed |